SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-013989
Filing Date
2024-05-02
Accepted
2024-05-02 16:25:48
Documents
2
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 8345
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 2985
  Complete submission text file 0001127602-24-013989.txt   12936
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 126 EAST LINCOLN AVENUE PO BOX 2000 RAHWAY NJ 07065
Business Address
Larson Betty D (Reporting) CIK: 0001617903 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 24908833